CCCC vs EIX
C4 Therapeutics Inc (CCCC) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
CCCC currently screens at market cap $425.7M. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the CCCC and EIX stock pages for the full models.
Not investment advice.